Acceptance and Commitment Therapy (ACT) for Family Members After a First Psychotic Attack
Launched by SAGLIK BILIMLERI UNIVERSITESI · Oct 22, 2024
Trial Information
Current as of July 23, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is a pretest, posttest, follow-up, randomized controlled experimental study. This study will be conducted with family members of individuals diagnosed with FPA who come to the psychiatry outpatient clinic of a training and research hospital. According to the results of G-power analysis, the minimum sample size of the study was calculated as 32 (intervention 16, control 16). Personal Information Form will be applied to the individuals before randomization. The computer-aided https://www.random.org/integers/ program will be used to assign the intervention and control groups without...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Acceptance to participate in the research,
- • Being responsible for the care of an individual who has been diagnosed with schizophrenia and other psychotic disorders according to DSM-5 diagnostic criteria at least six months ago and at most five years ago,
- • Living with the patient for at least one year,
- • First-degree relatives (mother, father, siblings, adult children and spouse),
- • The home environment is suitable for online interviewing (having a computer/smartphone, internet at home, the patient can be alone in the room during the session, etc.),
- • Being literate,
- • Communication is not a problem.
- Exclusion Criteria:
- • Refusal to participate in the research,
- • Responsible for the care of an individual diagnosed with schizophrenia and other psychotic disorders for less than six months or more than five years according to DSM-V diagnostic criteria,
- • Living with the patient for less than one year,
- • No first-degree relatives (mother, father, siblings, adult children and spouse),
- • The home environment is not suitable for online counseling (having a computer/smartphone, internet at home, the patient can be alone in the room during the session, etc.),
- • Illiteracy,
- • Communication problems.
About Saglik Bilimleri Universitesi
Saglik Bilimleri Universitesi, or the University of Health Sciences, is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university focuses on translating scientific discoveries into practical applications that enhance patient care and public health outcomes. Its commitment to rigorous ethical standards and comprehensive training equips researchers and healthcare professionals to contribute effectively to the global medical community. Through its clinical trial initiatives, Saglik Bilimleri Universitesi aims to address pressing health challenges and foster the development of new therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Trial Officials
Duygu Özer, Asst. Prof.
Principal Investigator
Bartın Unıversity
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported